To capture population structure specific to the UKBB cohort, we performed principal component analysis of ~150,000 UKBB samples using ~100,000 SNPs
More aggressive cardio schedules risk muscle catabolism, fatigue, and reduced training performance
Tirzepatide side effects are often most noticeable: during the first days or weeks of treatment in the days after a dose increase when restarting treatment after a break Most people start at 2.5 mg once a week, and the dose goes up in steps of 2.5 mg no sooner than every 4 weeks
When discussing therapy options, explain both the cardiovascular benefits and the possibility of small autonomic changes
UK Evidence & Safety Weight loss injections, particularly GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda), are increasingly prescribed in the UK for obesity management